India's Healthcare Industry: Innovation in Healthcare Delivery, Financing, and Manufacturing
Notice bibliographique
Résumé
Lawton Robert Burns, ed. India's Healthcare Industry: Innovation in Healthcare Delivery, Financing, and Manufacturing New Delhi, India: Cambridge University Press, 2014Lawton R. Burns is Chair of Department of Health Care Management at Wharton School at University of Pennsylvania. Professor Burns' background is in Sociology (PhD) and Health Administration (MBA), both from University of Chicago. His research preoccupations are with what is called supply chain (Burns, 2002) and innovation (Burns, 2012). He has also produced a substantial textbook (Burns, 2011). His overall focus is on healthcare from a business perspective.Burns' early contributions involved discussions of matters such as the strategies of group purchasing organizations and wholesaler/distributors, the role of e-commerce in care value chain, insights into hospital customer of future, and advice to health care executives to form alliances, increase their market power, and gain competitive advantage. He has continued in same vein (so to speak) as he has explained how best to form strategic alliances and partnerships ... between pharmaceutical firms/distributors, disposable manufacturers, medical device manufacturers, group purchasing organizations, and organized delivery systems. If he deals with healing at all, it most likely concerns proper managerial therapy to be applied when commercial facilities begin to bleed money.Dr. Burns is plainly good at what he does. His studies are read to advantage by investors, executives, managers and students of industry, a vast and growing field on a planet where population growth is arguably exceeding what environmentalists call Earth's carrying capacity. Every reasonable effort is being made to provide acute and chronic care to so many people that budgets in prosperous countries normally come close to 10% of Gross National Product and incessant demands for more resources are being made both in advanced and in underdeveloped countries. Add to this enthusiasm for high technology diagnostic and therapeutic devices at one end and imminent threat of pandemics at other, and it is easy to see that industry is prospering like few others.Burns is a successful contributor who has certainly provided invaluable advice to all who wish to get involved. For example, as a Visiting Professor at University of Wisconsin's Department of Preventative Medicine, he taught physicians about intricacies of corporate strategy. Few lessons could be more valuable. Indeed, he would probably not be insulted to carry title of unofficial guru to pharmaceutical-medical complex. In fact, it would not surprise me to learn that people who persuaded President Obama to drop prospect of a single-payer universal insurance system from his deliberations about American Affordable Care Act had been avid readers of Burns' books.In volume under review, Professor Burns has taken his expertise and applied it to very different circumstances than those experienced by most of his compatriots in domestic American healthcare industry. He examines conditions and possibilities for expansion in India as a vital new frontier for investment and profitable product delivery. There are evidently extraordinary opportunities for industry growth in this still poor, but potentially ever more powerful economy.Like generations of experts before him, main features of Burns' approach were developed in USA, but they are applied elsewhere under a general template for development that purports to be universal. So confident is he in his model for medical modernization that he is currently at work on a book that will examine situation in China and explain how to exploit openings there as well. According to Burns (Knowledge@Wharton, 2011), the trends in China are remarkably similar to what has happened to [healthcare] sector in India. …
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction distillée sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.
Scores Codex et Gemma par catégorie
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,004 | 0,000 |
| Méta-épidémiologie (sens strict) | 0,000 | 0,000 |
| Méta-épidémiologie (sens large) | 0,000 | 0,000 |
| Bibliométrie | 0,001 | 0,002 |
| Études des sciences et des technologies | 0,000 | 0,000 |
| Communication savante | 0,000 | 0,000 |
| Science ouverte | 0,000 | 0,000 |
| Intégrité de la recherche | 0,000 | 0,001 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,000 | 0,000 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».